[go: up one dir, main page]

GB2368846B - Isolated Jaagsiekte retroviruses (JSRV), gene delivery vectors, and methods of use - Google Patents

Isolated Jaagsiekte retroviruses (JSRV), gene delivery vectors, and methods of use

Info

Publication number
GB2368846B
GB2368846B GB0203028A GB0203028A GB2368846B GB 2368846 B GB2368846 B GB 2368846B GB 0203028 A GB0203028 A GB 0203028A GB 0203028 A GB0203028 A GB 0203028A GB 2368846 B GB2368846 B GB 2368846B
Authority
GB
United Kingdom
Prior art keywords
jsrv
jaagsiekte
retroviruses
isolated
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0203028A
Other versions
GB0203028D0 (en
GB2368846A (en
Inventor
Hung Y Fan
Massimo Palmarini
James M Sharp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
University of California Berkeley
Original Assignee
University of California
University of California Berkeley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, University of California Berkeley filed Critical University of California
Publication of GB0203028D0 publication Critical patent/GB0203028D0/en
Publication of GB2368846A publication Critical patent/GB2368846A/en
Application granted granted Critical
Publication of GB2368846B publication Critical patent/GB2368846B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/12011—Betaretrovirus, e.g. mouse mammary tumour virus
    • C12N2740/12021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/12011—Betaretrovirus, e.g. mouse mammary tumour virus
    • C12N2740/12041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/12043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB0203028A 1999-07-08 2000-07-08 Isolated Jaagsiekte retroviruses (JSRV), gene delivery vectors, and methods of use Expired - Fee Related GB2368846B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14286899P 1999-07-08 1999-07-08
PCT/US2000/018856 WO2001004266A1 (en) 1999-07-08 2000-07-08 A lung cancer associated retrovirus, gene delivery vector and methods of use thereof

Publications (3)

Publication Number Publication Date
GB0203028D0 GB0203028D0 (en) 2002-03-27
GB2368846A GB2368846A (en) 2002-05-15
GB2368846B true GB2368846B (en) 2004-08-25

Family

ID=22501614

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0203028A Expired - Fee Related GB2368846B (en) 1999-07-08 2000-07-08 Isolated Jaagsiekte retroviruses (JSRV), gene delivery vectors, and methods of use

Country Status (3)

Country Link
AU (1) AU6085500A (en)
GB (1) GB2368846B (en)
WO (1) WO2001004266A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9969980B2 (en) * 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
WO2004104032A2 (en) 2003-05-14 2004-12-02 The University Of Iowa Research Foundation Methods and compositions related to high-titer pseudotyped retroviruses
MX337213B (en) 2008-06-30 2016-02-17 Tocagen Inc Formulations of 5-fluorocytosine and uses thereof.
JP5684130B2 (en) 2008-09-26 2015-03-11 トカジェン インコーポレーテッド Recombinant vector
US8829173B2 (en) 2008-09-26 2014-09-09 Tocagen Inc. Recombinant vectors
WO2012058673A2 (en) 2010-10-31 2012-05-03 Tocagen Inc. Enhanced cancer treatment and monitoring using recombinant vectors
EP3623478A1 (en) * 2012-10-25 2020-03-18 Tocagen Inc. Retroviral vector with mini-promoter cassette
US9642921B2 (en) 2012-12-20 2017-05-09 Tocagen Inc. Cancer combination therapy and recombinant vectors
ES2779149T3 (en) 2014-03-26 2020-08-13 Tocagen Inc Retroviral vector that has immunostimulatory activity
WO2017040815A1 (en) 2015-09-04 2017-03-09 Tocagen Inc. Recombinant vectors comprising 2a peptide
CN115433719B (en) * 2022-10-10 2024-10-18 吉林大学 Sheep-derived immortalized cell line for preparing various viruses

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676455A1 (en) * 1991-05-17 1992-11-20 Inst Nat Sante Rech Med Retrovirus JSRV - Nucleic acid and proteins characteristic of this retrovirus - their applications in diagnosis and therapy
US5849718A (en) * 1994-12-19 1998-12-15 Medical Research Council Targeting complexes and use thereof
US5858990A (en) * 1997-03-04 1999-01-12 St. Elizabeth's Medical Center Fas ligand compositions for treatment of proliferative disorders

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676455A1 (en) * 1991-05-17 1992-11-20 Inst Nat Sante Rech Med Retrovirus JSRV - Nucleic acid and proteins characteristic of this retrovirus - their applications in diagnosis and therapy
US5849718A (en) * 1994-12-19 1998-12-15 Medical Research Council Targeting complexes and use thereof
US5858990A (en) * 1997-03-04 1999-01-12 St. Elizabeth's Medical Center Fas ligand compositions for treatment of proliferative disorders

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
J. CLIN. INVEST., 1990, 86, 1945-1953, TJ STANDIFORD ET AL *
J. VIR., 1991, 65, 5061-5067, DF YORK ET AL *
J. VIR., 1992, 66, 4930-4939, DF YORK ET AL *

Also Published As

Publication number Publication date
WO2001004266A9 (en) 2002-09-12
GB0203028D0 (en) 2002-03-27
GB2368846A (en) 2002-05-15
WO2001004266A1 (en) 2001-01-18
AU6085500A (en) 2001-01-30

Similar Documents

Publication Publication Date Title
AU5455900A (en) Heart homing peptides and methods of using same
AU3869400A (en) Human cancer associated gene sequences and polypeptides
EP1803733A3 (en) Use of a polypeptide comprising the extracellular domains of IL-20RA and IL-20RB for the treatment of inflammation
AU3877500A (en) Methods for preparing 3-aryloxy-3-arylpropylamines and intermediates thereof
ZA200107284B (en) Stable recombinant influenza viruses free of helper viruses.
AU2484399A (en) Controlled release delivery of peptide or protein
GB2368846B (en) Isolated Jaagsiekte retroviruses (JSRV), gene delivery vectors, and methods of use
IL231502A0 (en) Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
DK1025237T3 (en) Human checkpoint kinase, hCDS1, preparations and methods
NO20016247D0 (en) Streptogramin derivatives, their preparation and preparations containing the derivatives
AU4089899A (en) Stable envelope proteins for retroviral, viral and liposome vectors and use in gene and drug therapy
HRP20020372A2 (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
IL146381A0 (en) Methods for protein purification using aqueous two-phase extraction
EP0816504A3 (en) Platelet activating factor acetylhdrolase, and gene thereof
WO2001042287A3 (en) Putative human g-protein coupled receptors
AU2001266347A1 (en) Enteric preparations containing physiologically active peptides
BG106534A (en) Oral solution containing galanthamine and a sweetening agent
AU4096100A (en) Pseudotyped retroviral vector for gene therapy of cancer
AU3004101A (en) Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides
AUPQ599500A0 (en) Novel peptides, modulatory agents therefor and methods of using them
AU2002316788A1 (en) Retroviral vectors for gene therapy
ZA200108398B (en) Anti-HIV-1 vaccine comprising all or part of the HIV-1 Tat protein.
AU7036398A (en) Upar mimicking peptide
WO2001025430A3 (en) Novel human membrane proteins
AU1415301A (en) Use of peptide

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20100708